Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,762,999
-
Share change
-
+3,987,534
-
Total reported value
-
$175,238,641
-
Put/Call ratio
-
0%
-
Price per share
-
$8.84
-
Number of holders
-
78
-
Value change
-
+$35,210,718
-
Number of buys
-
44
-
Number of sells
-
35
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q1 2020
As of 31 Mar 2020,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,762,999 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BANK OF AMERICA CORP /DE/, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., INGALLS & SNYDER LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.